Matches in Nanopublications for { ?s ?p "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1242103.RAgxQdAuLcZXHZbMTXiPd5B_scGW3bbGx12cdTUuMPRR8130_assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242103.RAgxQdAuLcZXHZbMTXiPd5B_scGW3bbGx12cdTUuMPRR8130_provenance.
- NP1242104.RAs80pv8Dg3ztMOez-Plr4uHF08QkqBsiVjmG1epHUtzs130_assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242104.RAs80pv8Dg3ztMOez-Plr4uHF08QkqBsiVjmG1epHUtzs130_provenance.
- NP1242100.RALJCeTU1X95UrmuYR-f46rLSaEDaoG_NeY5aWd__XIuM130_assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242100.RALJCeTU1X95UrmuYR-f46rLSaEDaoG_NeY5aWd__XIuM130_provenance.
- NP1242102.RAOBMzlefUv9xjddE2ZjqTnjLZgCk2YvjiPhqeUkJxkmw130_assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242102.RAOBMzlefUv9xjddE2ZjqTnjLZgCk2YvjiPhqeUkJxkmw130_provenance.
- NP1242105.RAKnTUs95bRxDPX1wofsVImqIwV8-Hg65ZXPJADXLJj_0130_assertion description "[LncRNA CASC2 (cancer susceptibility candidate 2) has been characterized as a tumor suppressor in endometrial cancer and colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242105.RAKnTUs95bRxDPX1wofsVImqIwV8-Hg65ZXPJADXLJj_0130_provenance.